top of page

CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial

Product details

Registration number: SIN14988P

Classification: Prescription Only

Active ingredients: Cefepime dihydrochloride monohydrate 2378.5mg eqv cefepime

Strength: 2000 mg/vial

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

ATC code: J01DE01

HSA approval date: 12 April 2016

Manufacturer(s):

  • Labesfal Laboratorios Almiro S.A. (Fresenius Kabi Group)(primary and secondary packing)
  • Fresenius Kabi iPSUM S.R.L

Manufacturing country/countries: ITALY; PORTUGAL

What are the HSA registration number and classification for CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14988P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Cefepime dihydrochloride monohydrate 2378.5mg eqv cefepime

Strength: 2000 mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial?

According to the HSA dataset updated 7 August 2026:

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Labesfal Laboratorios Almiro S.A. (Fresenius Kabi Group)(primary and secondary packing)
  • Fresenius Kabi iPSUM S.R.L

Manufacturing country/countries: ITALY; PORTUGAL

Source for this answer

Where can I look up CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14988P or the exact product name CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial. The general register link does not preselect this product.

Source for this answer

What are the source dates for this CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 g/vial record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14988P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page